Skip to main content

Prophylaxis of infection-induced kidney stone formation

Urological Research volume 18, pages S45–S48 (1990)Cite this article

Summary

Lowering supersaturation with respect to struvite and carbonate apatite is the most important prophylactic measure in patients with infection-induced kidney stone disease. This is best achieved by combining culture-specific antibiotics with urinary acidification. Urinary infection with non-urease-producing Escherichia coli, probably promoting struvite particle formation, must be eradicated. Possible measures for improving urothelial anti-adherence properties or reducing bacterial adherence are discussed.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Ackermann D, Baumann JM, Siegrist P (1990) Therapy with l-methionine: effects on urinary composition and on systemic acid-base behaviour. In: Vahlensieck W, Gasser G, Hesse A, Schoeneich G (eds) Proceedings of the 1st European Symposium on Urolithiasis. Excerpta Medica, Amsterdam, p 192

    Google Scholar 

  2. Bagley DH (1987) Pharmacologic treatment of infection stones. Urol Clin North Am 14:347

    Google Scholar 

  3. Grenabo L, Hedelin H, Pettersson S (1986) The inhibitory effect of human urine on urease-induced crystallization in vitro. J Urol 135:416

    Google Scholar 

  4. Grenabo L, Hedelin H, Pettersson S (1988) Adherence of ureaseinduced crystals to rat bladder epithelium. Urol Res 16:49

    Google Scholar 

  5. Griffith DP (1978) Struvite stones. Kidney Int 13:372

    Google Scholar 

  6. Griffith DP, Osborne CA (1987) Infection (urease) stones. Miner Electrolyte Metab 13:278

    Google Scholar 

  7. Griffith DP, Gleeson MJ (1989) Renal infections and stones. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG (eds) Urolithiasis. Plenum Press, New York, p 269

    Google Scholar 

  8. Griffith DP, Khonsari F, Skurnick JH, James KE, Veterans Administrations Cooperative Study Group (1988) A randomized trial of acetohydroxamic acid for the treatment and prevention of infection-induced urinary stones in spinal-cord injury patients. J Urol 140:318

    Google Scholar 

  9. Hedelin H, Bratell S, Grenabo L, Pettersson S (1989) The bacteriology of operated renal stones. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG (eds) Urolithiasis. Plenum Press, New York, p 291

    Google Scholar 

  10. Hedelin H, Grenabo L, Hugosson J, Larsson P, Pettersson S (1989) E. coli — a promoting factor in the development of phosphate stones? In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG (eds) Urolithiasis. Plenum Press, New York, p 289

    Google Scholar 

  11. Hedelin H, Grenabo L, Pettersson S (1990) The effects of fractionated human urine on urease-induced crystallization in vitro. Urol Res 18:35

    Google Scholar 

  12. Jarrar K, Graef V, Boedeker HR (1990) Acimethin therapy of the infection stone: results of a long term study. In: Vahlensieck W, Gasser G, Hesse A, Schoeneich G (eds) Proceedings of the 1st European Symposium on Urolithiasis. Excerpta Medica, Amsterdam, p 195

    Google Scholar 

  13. Kobashi K, Hase J, Uehara K (1962) Specific inhibition of urease by hydroxamic acid. Biochim Biophys Acta 65:380

    Google Scholar 

  14. Lerner SP, Gleeson MJ, Griffith DP (1989) Infection stones. J Urol 141:753

    Google Scholar 

  15. Lotz M, Zisman E, Bartter FC (1968) Evidence for a phosphorus depletion syndrome in man. N Engl J Med 278:409

    Google Scholar 

  16. Martelli A, Buli P, Brunocilla E (1982) Propionohydroxamic acid in infected renal stones. J Urol 128:1130

    Google Scholar 

  17. Martelli A, Buli P, Spatafora S (1986) Clinical experience with low dosage of propionohydroxamic acid (PHA) in infected renal stones. Urology 28:373

    Google Scholar 

  18. Murphy FJ, Zelman S (1965) Ascorbic acid as a urinary acidifying agent: 1. Comparison with the ketogenic effect of fasting. J Urol 94:297

    Google Scholar 

  19. Murphy FJ, Zelman S, Mau W (1965) Ascorbic acid as a urinary acidifying agent: 2. Its adjunctive role in chronic urinary infection. J Urol 94:300

    Google Scholar 

  20. Orskov I, Orskov F, Birch-Andersen A (1980) Comparison of Escherichia coli fimbrial antigen F7 with type 1 fimbriae. Infect lmmun 27:657

    Google Scholar 

  21. Orskov I, Ferencz A, Orskov F (1980) Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli. Lancet I:887

    Google Scholar 

  22. Parsons CL (1982) Prevention of urinary tract infection by the exogenous glycosaminoglycan sodium pentosanpolysulfate. J Urol 127:167

    Google Scholar 

  23. Parsons CL (1986) Pathogenesis of urinary tract infection: bacterial adherence, bladder defense mechanisms. Urol Clin North Am 13:563

    Google Scholar 

  24. Parsons CL, Mulholland SG (1987) Successful therapy of interstitial cystitis with pentosanpolysulfate. J Urol 138:513

    Google Scholar 

  25. Parsons CL, Stauffer C, Mulholland SG, Griffith DP (1984) Effect of ammonium on bacterial adherence to bladder transitional epithelium. J Urol 132:365

    Google Scholar 

  26. Pizzarelli F, Peacock M (1987) Effect of chronic administration of ammonium sulfate on phosphatic stone recurrence. Nephron 46:247

    Google Scholar 

  27. Sallis JD, Thomson R, Rees B, Shankar R (1988) Reduction of infection stones in rats by combined antibiotic and phosphocitrate therapy. J Urol 140:1063

    Google Scholar 

  28. Shorr E, Carter AC (1950) Aluminum gels in the management of renal phosphatic calculi. JAMA 144:1549

    Google Scholar 

  29. Silverblatt FJ (1974) Host-parasite interactions in the rat renal pelvis. J Exp Med 140:1696

    Google Scholar 

  30. Svanborg Edén C, Freter R, Hagberg L, Hull R, Hull S, Leffler H, Schoolnik G (1982) Inhibition of experimental ascending urinary tract infection by epithelial cell-surface receptor analogue. Nature 298:560

    Google Scholar 

  31. Westenfellner M, Ungemach G (1981) l-Methionin zur Ansäuerung des Urins. Therapiewoche 31:5197

    Google Scholar 

  32. Williams JJ, Rodman JS, Peterson CM (1984) A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N Engl J Med 311:760

    Google Scholar 

Download references

Author information

Affiliations

  1. Policlinic of Medicine, University of Berne, Berne, Switzerland

    B. Hess

Authors
  1. B. Hess
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hess, B. Prophylaxis of infection-induced kidney stone formation. Urol. Res. 18, S45–S48 (1990). https://doi.org/10.1007/BF00301528

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00301528

Key words

  • Infection-induced kidney stone formation
  • Lowering struvite/carbonate apatite supersaturation
  • Urinary inhibitors and promoters
  • Urothelial antiadherence properties and bacterial adherence